The Democrat-backed legislation to lower drug prices was defeated in a House committee after three moderate Democrats voted against their own party’s measure.
Democratic Reps. Kurt Schrader of Oregon, Scott Peters of California, and Kathleen Rice of New York voted against the plan to allow the secretary of Health and Human Services to negotiate lower drug prices, The Hill reported.
Liberals immediately attacked the three moderates Democrats and accused them of being beholden to the pharmaceutical industry.
“Reps. Peters, Rice, and Schrader are prioritizing drug company profits over lower drug prices for the American people, particularly for patients with chronic conditions such as diabetes and multiple sclerosis,” said Patrick Gaspard, president of the left-leaning Center for American Progress.
“To the contrary of what they contend, their opposition to the drug’s proposal threatens the entirety of President Joe Biden’s Build Back Better agenda, which Democrats have campaigned on for years and that they previously voted for,” he added.